$CBIS Stock Message Board and Forum

New Post Public Reply Private Reply Replies (0) Message Board

Feb 18, 2014 at 6:28 PM

$CBIS

Stock Message Board and Forum http://investorshangout.com/search?q=CBIS&...mp;yt0=Go!

##### recent news/filings ~ source: finance.yahoo.com

Thu, 13 Feb 2014 14:36:00 GMT ~ Cannabis Science (CBIS) Signs Partnership Agreement with Michigan Green Technologies, LLC to Focus on Reform and Proper Implementation of Cannabis and Commercial Hemp Programs for the State of Michigan
- COLORADO SPRINGS, Colo., Feb. 13, 2014 /PRNewswire/ -- Cannabis Science, Inc. (NASD OTC: CBIS), a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, is proud to announce its new partnership with Michigan Green Technologies, LLC that has a broad focus on the reform and proper implementation of state approved cannabis and commercial hemp programs with comprehensive seed to sale process to include cultivation; Robert Kane, Director and CFO of Cannabis Science, stated, "We feel privileged to participate in the transformation of Michigan's state hemp and cannabis laws that will contribute to creating new agricultural, medical, and research systems. Michigan has always been an important market, and with a population twice the size of Colorado's, we see many opportunities ahead through our new venture with Michigan stakeholders. It is anticipated that these platforms will serve as best practices in state-wide cannabis and hemp reform, providing substantial agricultural opportunity as well as guiding the effective integration of medical cannabis into state healthcare systems.
read full: http://finance.yahoo.com/news/cannabis-scienc...00262.html
*********************************************************

Wed, 05 Feb 2014 17:48:00 GMT ~ Cannabis Science (CBIS) Collaborates with Patients Out of Time, Inc., a Global Patient Advocacy Organization Dedicated to Educating Health Professionals and the Public about Therapeutic Cannabis
- COLORADO SPRINGS, Colo., Feb. 5, 2014 /PRNewswire/ -- (NASD OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, provides development consultation and financial support to Patients Out of Time, Inc., the premiere non-profit organization devoted to helping educate the public and healthcare professionals about the safety and effectiveness of medical cannabis. Cannabis Science is pleased to facilitate the critical work of this unique non-profit organization's ongoing conferences, events, workshops and global distribution of leading edge educational content and online resources. CBIS's support includes supporting Patients Out of Time's marquee conference in Portland, Oregon in May 2014, entitled "The Eighth National Clinical Conference on Cannabis Therapeutics", and future conferences, helping to expand the organization's conferences from biennial to annual, for which participants or learners may earn ACCME (fully recognized continuing education) credits.
read full: http://finance.yahoo.com/news/cannabis-scienc...00369.html
*********************************************************

Tue, 04 Feb 2014 13:52:00 GMT ~ Cannabis Science (CBIS) Applauds U.S. Congress on Moving to Legalize Hemp Cultivation and Research; Calls Today for Final Senate Passage of Farm Bill and President's Signature into Law
- COLORADO SPRINGS, Colo., Feb. 4, 2014 /PRNewswire/ -- Cannabis Science, Inc. (CBIS), a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, is pleased that the U.S. Congress and President Obama appear positioned to approve the first federal law to legalize hemp cultivation and advanced research on a federal level, creating unprecedented opportunities for the Company to pursue patient-based pharmaceutical solutions for patients. Last week the U.S. House of Representatives approved the "farm bill" that contains a provision for certain cultivation of industrial hemp for research in a number of U.S. states. The Senate is expected to approve the measure as soon as today, and President Obama has declared that he will sign the bill into law, changing the legal landscape for the entire hemp industry. "As hemp and cannabis both come from the same plant, federal movement on liberalization of hemp cultivation and research will positively impact Cannabis Science's opportunities for pharmaceutical research and development of cannabis and cannabinoid-based pharmaceutical products for patients. The House has approved the bill, and the Senate is expected vote in favor of it today or tomorrow, with near certain approval from the President. The Company is formulating its strategy for this regulatory opening to more quickly bring pharmaceutical products to market for the benefit of patients in need," said Chad S. Johnson, Chief Operating Officer and General Counsel of Endocan Corporation.
read full: http://finance.yahoo.com/news/cannabis-scienc...00205.html
*********************************************************

Mon, 03 Feb 2014 13:26:00 GMT ~ CBIS Provides Growth Guidance on its Medicine Dispensing Systems (MDS) Exclusive & Non-Exclusive Agreements
- COLORADO SPRINGS, Colo., Feb. 3, 2014 /PRNewswire/ -- (NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, provides ...
read full: http://finance.yahoo.com/news/cbis-provides-g...00614.html
*********************************************************

Wed, 29 Jan 2014 17:55:00 GMT ~ Cannabis Science (CBIS) Government Affairs Representative Lobbys' with the U.S. House of Representatives' Cannabis Caucus for President Obama to Join Congressional Cannabis Caucus in Ending Federal Restrictions on Cannabinoid Research
- COLORADO SPRINGS, Colo., Jan. 29, 2014 /PRNewswire/ -- (NASDAQ OTC: CBIS) After President Obama's State of the Union Address this week, Cannabis Science is leading the private sector effort to take cannabis-derived drugs to market. The company's government relations team lead, Rick Blake, is working with the U.S. House of Representatives' Cannabis Caucus to ensure that the President signs an Executive Order to decriminalize cannabis research. This is one of the bipartisan initiatives of the Members of the Cannabis Caucus being facilitated by Cannabis Science. In contrast to many other countries, the regulatory landscape of the United States creates unreasonable restrictions on the ability of scientists and physicians to explore promising patient-driven research involving cannabis and cannabinoids. "Thousands of patients are awaiting the President's action to set cannabis research free," said Dorothy Bray, Ph.D., Director and CEO of Cannabis Science, Inc., one of the leading supporters of scientific cannabis drug development in the private sector. We applaud those congressional members in Colorado, California, Oregon, New York, Massachusetts and many other jurisdictions in the United States who have determined to take forward U.S. cannabis drug research." Dr. Bray and others on the CBIS team support critical legislation for the use of cannabis in the treatment of multiple illnesses including cancer.
read full: http://finance.yahoo.com/news/cannabis-scienc...00858.html
*********************************************************

##### chart ~ source: stockcharts.com

http://stockcharts.com/h-sc/ui?s=CBIS&p=D...3180572698

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=CBIS&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CBIS/company-info
Ticker: $CBIS
OTC Market Place: OTCQB
CIK code: 0001024626
Company name: Cannabis Science, Inc.
Company website: http://www.cannabisscience.com
Incorporated In: NV, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CBIS/filings
Latest financials: http://www.otcmarkets.com/stock/CBIS/financials
Latest news: http://www.otcmarkets.com/stock/CBIS/news - http://finance.yahoo.com/q/h?s=CBIS+Headlines

Major holdings: http://data.cnbc.com/quotes/CBIS/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CBIS+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CBIS.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CBIS

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Cannabis+Science%2...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...nce%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.cannabisscience.com
Alexa: http://www.alexa.com/siteinfo/http://www.cann...ience.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.cannabisscience.com

http://www.pennystocktweets.com/stocks/profile/CBIS

##### last known share structure ~ source: otcmarkets.com

Market Value: $139,246,142 a/o Feb 14, 2014
Shares Outstanding: 761,323,906 a/o Nov 18, 2013
Float: 24,000,000 a/o Jun 17, 2010
Authorized Shares: 250,000,000 a/o Jun 17, 2010
Par Value: 0.001

##### business description ~ source: otcmarkets.com

Research & Development of medical cannabis compounds

Stock Message Board and Forum http://investorshangout.com/search?q=CBIS&...mp;yt0=Go!

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ex-Guard Pushes Cost-Saving Grille Guards as Deer Season Hits

Deer Season's Bumper Problem If you're driving a hefty pickup or van in the thick of deer season, forget looking at pretty autumn leaves. Instead, brace for the telltale thud—and the ensuing financial headache—that comes with a deer collision. Anyone who's tangled with such a mishap knows it's not just about the dent in your fender; it's about your wallet getting...

Meitu Sees Soaring Subscriber Growth Amid AI Focus

Subscriber Growth Hits a Record High Well, here's a headline to chew on—Meitu, Inc. is boasting a whopping 19.83 million paying subscribers, setting a new milestone. That's 1.39 million new users this quarter alone, the most significant uptick they've seen in four cycles. Not that I'm surprised; when you've got a product mix like theirs that's riding high on the wave of...

Nicely Network: A Game-Changer for B2B SaaS Marketing

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Tabañero Spices Up Holidays with $10 Gift Sets

Hot Sauce, Spicy Gifting, and Bold Barbecue When holiday cheer mixes with a dash of heat, you end up with something as electrifying as Tabañero's latest offerings. This Florida-based player is nudging its way into the gift-giving scene with a lineup that's as spicy as it is thoughtful. Frankly, if you're scrambling for stocking stuffers or a memorable Secret Santa...

Honeywell Aerospace Posts Solid Q3, Raises Guidance

Honeywell Aerospace Surprises with Strong Third Quarter In a world where numbers are often as slippery as a greased pig, Honeywell Aerospace (NASDAQ:HONA) has managed to pin down a surprisingly robust third quarter. Let’s break it down: they’ve claimed sales of a cool $4.6 billion, reflecting a 2% bump both in reported and organic revenue from the previous year, and...

ZYNLONTA's Japanese Push: ADC Therapeutics Gains Traction

ADC Therapeutics Eyes Japan with ZYNLONTA Bet These days, everyone seems to have their eyes on the Far East, and ADC Therapeutics is no exception. They're making a strategic leap by letting their budding blockbuster ZYNLONTA make waves in Japan. With the fresh file submitted for approval, it looks like they're hoping to capture market ground that could pay off big time...

Factory-Built Homes Take Center Stage in New Doc Short

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Virax Biolabs Expands China Reach With Key Partnerships

Virax Biolabs' Strategic Play in China Does Virax Biolabs have a trick up its sleeve, or is it just rolling the dice in the vast Chinese market? With three new distributor agreements, it sure seems like it's trying to tip the scales in its favor. The London-based company announced new distribution agreements for its ImmuneSelect research-use immune profiling products....

Withings Sleep Care Service Tackles Post-Time Change Fatigue

Counting Sheep: More Minutes or Just More Trouble? As Americans prepare for the clocks to fall back, many dream of an extra hour of sleep. But according to Withings, the reality is far less restful. Despite the clock change promising more shut-eye, folks average just 11 minutes extra sleep, only to watch that dissipate in the days following. Somehow, we lose more than we...

Corgi Revamps Malpractice Insurance for Healthcare Sector

Streamlining Insurance for Healthcare Professionals Here's one for the books in the insurance world: Corgi Insurance is stepping up to spare healthcare practices from the headache of getting medical malpractice coverage. This is more than just insurance talk; it's about time someone carved out a path through the labyrinth of medical malpractice policies. Healthcare folks...